Clinical Trials Browser

Withdrawn × Interventional × Colonic Neoplasms × Clear all

NCT01372696 2025-03-27

C-LST

Phase NA Withdrawn

Gastrointestinal

Colonic Neoplasms, Colonic Polyps

NCT03764137 2025-01-31

Panitumumab

Phase 1/2 Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT04093557 2024-12-12

Improving Outpatient Colonoscopy Bowel Prep with the Orton Score

Phase NA Withdrawn

Gastrointestinal

Colonic Neoplasms, Colonic Polyps

NCT05427344 2024-11-26

Effectiveness of Aquatic Exercise on Fatigue, Neuropathy and Quality of Life Among Cancer Patients

Phase NA Withdrawn

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT04488159 2024-09-20

iMAGINE

Phase 3 Withdrawn

Gastrointestinal

Colonic Neoplasms, Motor Activity

NCT05356897 2024-09-19

Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05672342 2024-08-09

Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT04231526 2024-07-31

Pembrolizumab in Early Stage Colon Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT05471401 2024-06-13

GI Organ Tracking Via Balloon Applicators

Phase NA Withdrawn

GastrointestinalGenitourinaryHead & NeckThoracic

Colonic Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT05900648 2024-04-29

Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05310565 2024-04-03

CCX

Phase NA Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT02519140 2023-12-04

Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections

Phase 3 Withdrawn

Gastrointestinal

Colonic Neoplasms, Stomach Neoplasms

NCT04799431 2023-05-09

Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer

Phase 1 Withdrawn

Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms

NCT05178576 2022-11-04

A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT05433402 2022-10-27

Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT04685551 2022-07-26

Improving Survivorship Among Minority Cancer Dyads

Phase NA Withdrawn

BreastGastrointestinalThoracic

Caregiver Burden, Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Neoplasms

NCT02201381 2022-07-18

METRICS

Phase 3 Withdrawn

BreastCNSGastrointestinalGynecologic

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT05104905 2022-05-11

RENACOL

Phase 1/2 Withdrawn

GastrointestinalGenitourinary

Carcinoma, Renal Cell, Colonic Neoplasms

NCT04831827 2021-10-27

Promoting Equity for Cancer Screening and Follow-up

Phase NA Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT03633539 2021-09-10

mSILSC

Phase NA Withdrawn

Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

NCT04511793 2021-07-19

Hepatic Artery Infusion (HAI) Program at Duke University

Phase NA Withdrawn

Gastrointestinal

Colonic Neoplasms, Liver Neoplasms, Cholangiocarcinoma

NCT00578396 2021-01-25

Phase I Biomarker Study of Dietary Grape-derived Low Dose Resveratrol for Colon Cancer Prevention

Phase 1 Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT04270461 2020-10-22

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Phase 1 Withdrawn

CNSGastrointestinal

Colonic Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Medulloblastoma

NCT03408561 2019-09-17

Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer

Phase NA Withdrawn

BreastGastrointestinalGenitourinaryLymphoidThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Lymphoma, Prostatic Neoplasms

NCT03946033 2019-08-30

PROSCORE

Phase NA Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT00005030 2018-11-14

SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver

Phase 1 Withdrawn

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT03185416 2018-04-09

EPIICC

Phase NA Withdrawn

Gastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular

NCT01919541 2018-03-22

Mechanistic Prehabilitation

Phase NA Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00388700 2018-02-14

A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT02774512 2017-10-06

ZAK-0

Phase EARLY_PHASE1 Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT00002664 2017-07-13

Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01095523 2017-07-02

Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases

Phase 2 Withdrawn

GastrointestinalGynecologic

Colonic Neoplasms, Neoplasm Metastasis, Peritoneal Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms

NCT01386502 2017-07-02

CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors

Phase 1 Withdrawn

BreastGastrointestinalGynecologicSarcoma

Breast Neoplasms, Colonic Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT01936961 2017-06-27

I-CREST

Phase NA Withdrawn

BreastGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Neoplasms, Triple Negative Breast Neoplasms

NCT00408772 2017-06-09

Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT01270438 2017-04-04

Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT01032590 2017-03-06

Internet-Based Weight-Loss Program for Colorectal Cancer Survivors

Phase NA Withdrawn

Gastrointestinal

Body Weight Changes, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02046538 2017-01-25

Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT01522677 2016-12-01

A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Photosensitivity Disorders

NCT00684229 2016-09-15

Regional Anesthesia in Colon Rectal Surgery

Phase NA Withdrawn

Gastrointestinal

Agnosia, Colonic Neoplasms

NCT00571740 2016-07-06

Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02575508 2016-05-20

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms

NCT01675934 2016-01-08

Right-sided Retroflexion With Standard Adult Versus Pediatric Colonoscopes

Phase NA Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT00735241 2015-05-22

FAST

Phase 2/3 Withdrawn

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT02235324 2015-05-06

Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT01882972 2015-04-15

Strength for Health

Phase NA Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT01941173 2014-07-21

Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy

Phase NA Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00035919 2014-05-22

Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver

Phase 1/2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT01320267 2014-03-17

SILS

Phase 1/2 Withdrawn

Gastrointestinal

Colonic Neoplasms

NCT00003786 2014-03-07

Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms